Table 4. Results for baseline and final assessments with the Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), and the Visual Analog Sleep Scales (VAS) in the two groups.

Variable/group/time	n	Mean (SD)	p-value*	Difference from baseline to final, mean (SD)	Comparison between EG and CG (p-value)
Anxiety symptoms
EG
1	14	18.21 (11.6)	0.02*	-8.64 (9.6)	0.80
2	11	8.45 (6.6)
CG
1	17	15.94 (11.8)	< 0.01*	-8 (9.4)
2	14	6.57 (8.5)
Depressive symptoms
EG
1	14	18.64 (6.6)	0.06	-5.91 (7.6)	0.46
2	11	13.09 (8.0)
CG
1	17	17.06 (10.4)	< 0.01*	-8.5 (7.8)
2	14	8.93 (8.4)
Sleep disturbances
EG
1	14	26.91 (11.6)	0.99	-0.73 (15.5)	0.27
2	11	26.18 (18.2)
CG
1	17	26.57 (21.1)	0.27	-9.93 (21.2)
2	14	16.64 (14.0)
Sleep effectiveness
EG
1	14	9.27 (5.5)	0.40	3.73 (10.6)	0.37
2	11	13.00 (10.2)
CG
1	17	9.86 (11.4)	0.56	-1 (11.1)
2	14	8.86 (9.3)
Sleep supplementation
EG
1	14	5.64 (7.2)	0.77	-0.64 (8)	0.54
2	11	5.00 (6.0)
CG
1	17	4.71 (6.3)	0.07	-3.5 (6.5)
2	14	1.21 (2.0)

CG = control group; EG = experimental group; SD = standard deviation; time 1 = baseline assessment; time 2 = final assessment.

^*Statistically significant difference.